Cornerstone Therapeutics Inc. (NASDAQ:CRTX)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

Recs

0
Player Avatar withoutlimits (84.28) Submitted: 2/2/2010 3:07:38 PM : Outperform Start Price: $5.12 CRTX Score: -21.93

Looks Cheap!!!

Featured Broker Partners


Advertisement